1. Introduction {#s0005}
===============

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) causes a disease COVID-19 which originated in Wuhan, China ([@bb0060]). This disease has brought a wave of pandemic throughout the world. In this worrisome situation, undoubtedly vaccine is the primary prevention strategy to contain this virus. However, the development process of vaccine is time consuming and requires the analysis of genetic variability of the virus population so that effective and safe vaccine can be developed for heterogeneous human population ([@bb0030]). In this regard, Tung Phan has performed a genomic analysis to show the evolution of SARS-CoV-2 ([@bb0025]), subsequently, we have also analysed Indian SARS-CoV-2 genomes in ([@bb0035]). In continuation to these works, we have further conducted the genomic analysis of 566 SARS-CoV-2 virus population to identify the mutation as substitution, deletion, insertion and Single Nucleotide Polymorphism (SNP). Generally, 1% of the population which is being affected by substitution is termed as SNP. We have concerned ourselves with only non-synonymous mutations as they are responsible for changes in the amino acids. In order to find the genetic variability, the multiple sequence alignment (MSA) is very much essential in presence of reference sequence. On the other hand, it is also known that the multiple sequence alignment technique provides a near optimal result. Therefore, different alignment techniques can provide different results on the same pool of sequences. Hence, we have used four different well-known multiple sequence alignment techniques viz. ClustalW ([@bb0045]), MUSCLE ([@bb0005]), ClustalO ([@bb0040]) and MAFFT ([@bb0015]) in order to align the Indian 566 SARS-CoV-2 sequences. Subsequently, these aligned results are used to identify the lists of mutations as substitution, deletion, insertion and SNP. Thereafter, a consensus of these results, called as Consensus Multiple Sequence Alignment (CMSA), is prepared to have the final list of mutations so that the advantages of all four alignment techniques can be preserved. It is important to mention that the identification of SNPs can be helpful for the classification of virus strain and accordingly designing of vaccine and defining the dose of the vaccine can be done effectively ([@bb0010]).

Recently the metagenomic analysis using Next-Generation Sequencing (NGS) ([@bb0020]; [@bb0055]) shows that the SARS-CoV-2 is a single-stranded enveloped RNA virus with a genome length ranges from 27 to 32 kilobases ([@bb0050]). As reported in NCBI, SARS-CoV-2 has 11 coding regions that can encode ORF1ab polyproteins, spike (S) glycoprotein, envelope (E) protein, membrane (M) glycoprotein, nucleocapsid (N) protein and accessory proteins such as ORF3a, ORF6, ORF7a, ORF7b, ORF8 and ORF10. It has further been reported that Open Reading Frame (ORF) can encode several Non-Structural Proteins (NSP). The genomic orientation of SARS-CoV-2 virus is shown in Fig. S1(A) and their coordinates in Table S1 in supplementary. This is important to mention that the virus has a novel strain and the understanding of its genetic variability in different countries is still limited. This is yet another motivation to conduct this research for Indian SARS-CoV-2 sequences.

2. Materials and methods {#s0010}
========================

The recent genomic sequences of Indian SARS-CoV-2 virus have been collected from Global Initiative on Sharing All Influenza Data (GISAID)[2](#fn0010){ref-type="fn"} in fasta format. It contains 566 complete and near complete genomes with sequence ID. The average length of the 566 genomes is 29,831 bp. In addition to this, we have downloaded the Reference Sequence (NC_045512.2)[3](#fn0015){ref-type="fn"} from National Center for Biotechnology Information (NCBI) to conduct the experiment with 566 Indian SARS-CoV-2 genomes. For the data visualization and editing, BioEdit has been used.

We have applied four different Multiple Sequence Alignment (MSA) techniques: ClustalW ([@bb0045]), MUSCLE ([@bb0005]), ClustalO ([@bb0040]) and MAFFT ([@bb0015]) in order to align the Indian 566 SARS-CoV-2 sequences. ClustalW, ClustalO and MAFFT are progressive alignment techniques whereas MUSCLE is an iterative progressive alignment technique. Progressive alignment techniques use methods such as Needleman-Wunsch algorithm, Smith-Waterman algorithm etc. to complete the pairwise alignments and then the sequences are clustered together to show their relationships by using methods such as *k*-means algorithm. Iterative progressive alignment technique works similarly as the progressive alignment techniques but dynamic programming is repeatedly applied over here to realign the initial sequences. At the same time, it also appends new sequences to the growing MSA. The difference in the characteristics of the four methods adopted in this work is worth mentioning over here. ClustalW initially performs pairwise alignment of all sequences by using the *k*-tuple method. Thereafter, MSA is created by progressively aligning the most closely related sequences based on Neighbour-Joining guide tree method. ClustalO uses the *k*-tuple method to produce pairwise alignment. Then mBed is used to cluster the sequences followed by *k*-means clustering algorithm. Next, the guide tree is built using Unweighted Pair Group Method with Arithmetic Mean (UPGMA) method. Finally, MSA is constructed using the HHalign package. MAFFT uses two different heuristic methods, progressive (FFT-NS-2) and iterative refinement (FFT-NS-i). The main aim of MAFFT is to merge local and global algorithms for MSA. Initially, FFT-NS-2 is used to calculate all-pairwise distances to create a provisional MSA from which refined distances are calculated. Then, FFT-NS-i is performed to get the final MSA. In MUSCLE technique, two distance measures are used: *k*-mer for unaligned pairs and Kimura method for aligned pairs of sequences. Initially, a draft MSA is produced in MUSCLE using the *k*-mer method. Thereafter, a progressive alignment is constructed based on the guide tree as produced by the UPGMA method. This initial tree is then re-estimated using the Kimura distance method after which UPGMA method is once again used to produce a new guide tree, thereby creating a second MSA. New MSAs are finally created by realigning the two sequences created previously. Thus, we have used these four techniques to align and using these aligned sequences, identify the mutation in Indian virus sequences. These methods and the subsequent identification technique provide lists of mutations as substitution, deletion, insertion and SNP. Thereafter, a consensus of these results, called as Consensus Multiple Sequence Alignment (CMSA), is prepared to have the final list of mutations so that the advantages of all four alignment techniques can be preserved. This is to be noted that the identification technique to have the list of mutations from the alignment result can be found in our previous article ([@bb0035]) as well as mentioned in Fig. S1(B). The overall pipeline of the experiment is shown in [Fig. 1](#f0005){ref-type="fig"}(A).Fig. 1(A) Pipeline of the workflow (B) Examples of mutations like substitution, deletion and SNP (C) Venn diagram to represent the consensus results of four alignment techniques (D) BioCircos plot to represent the whole virus genome with the frequency of mutations in different tracks (E) SNPs present in more than 10% of population of Indian SARS-CoV-2 genomes.Fig. 1

3. Results {#s0015}
==========

The results of the experiment are reported in [Table 1](#t0005){ref-type="table"} . It shows that the CMSA identifies unique 767, 2025 and 54 substitutions, deletions and SNPs while the zero insertions are common among four methods. The detailed results are provided in Table S2 in supplementary. In Table S2, the results of each method and CMSA are reported separately. It contains coordinate position of mutation, number of occurrence of mutation in virus genome (frequency of mutation), change in nucleotide, change in amino acid, entropy to measure change at genomic location and mapping with coding region so that mutation point. Moreover, the venn diagrams of these results are shown in [Fig. 1](#f0005){ref-type="fig"}(C) while few examples of substitution, SNP and deletion are shown in [Fig. 1](#f0005){ref-type="fig"}(B) using BioEdit software.Table 1Mutation results of different methods on Indian SARS-CoV-2 Genomes.Table 1MethodAll MutationsSubstitutionDeletionInsertionSNPClustalW33849332449264MUSCLE33448482494265ClustalO33978932502266MAFFT33968882506266CMSA27927672025054

Further, the results of CMSA are also visualized using BioCircos plot in [Fig. 1](#f0005){ref-type="fig"}(D). Here whole virus genome with the coding regions is shown in the outer track while substitution, deletion, insertion and SNP are visualised in subsequent tracks where frequency of mutations is illustrated through bar and dot plots. It gives a complete visual representation about the frequency of the mutations. For example, in case of SNP, at coordinate positions, 241, 3037, 14,410, 23,405, the change in nucleic acid is close to 60% of the Indian virus population. Out of these four major changes, two of them are belonging in ORF1ab and one in the Spike gene. Apart from that, ORF3a, Membrane, ORF8, Nucleocapsid genes are also having SNPs. In [Fig. 1](#f0005){ref-type="fig"}(E), SNPs present in more than 10% of the Indian SARS-CoV-2 population is shown and subsequently reported in [Table 2](#t0010){ref-type="table"} . Moreover, the aligned sequences, code and additional results are provided in supplementary website.[4](#fn0020){ref-type="fn"} .Table 2Mutation as SNP present in more than 10% of population of Indian SARS-CoV-2 genomes.Table 2Coordinate of MutationFrequency of Mutation in GenomesType of MutationChange in NucleotideChange in Amino AcidAvg. EntropyMapped with Coding Region241342SubstitutionC \> TS \> L0.70125'-UTR3037340SubstitutionC \> TS \> F0.6944ORF1ab14,410332SubstitutionC \> TP \> L0.7174ORF1ab18,879117SubstitutionC \> TS \> F0.5216ORF1ab22,44669SubstitutionC \> TT \> I0.3702Spike23,405334SubstitutionA \> GD \> G0.7125Spike23,931165SubstitutionC \> TT \> I0.6789Spike25,565122SubstitutionG \> TR \> I0.5207ORF3a26,737112SubstitutionC \> TT \> I0.4969Membrane28,313174SubstitutionC \> TP \> L0.6883Nucleocapsid28,85671SubstitutionC \> TS \> L0.3899Nucleocapsid28,88364SubstitutionG \> AR \> K0.3825Nucleocapsid28,88464SubstitutionG \> AG \> N0.3848Nucleocapsid28,88564SubstitutionG \> CG \> T0.3848Nucleocapsid

4. Conclusion {#s0020}
=============

This study shows the genetic variability of Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques. The analysis shows 767, 2025 and 54 unique substitutions, deletions and SNPs are present in Indian SARS-CoV-2 genomes. More precisely, out of 54 SNPs, 4 SNPs are present close to the 60% of the virus population. These mutations are non-synonymous in nature. The reason behind these frequent mutations needs to be studied in future research. However, the motivation to find the SNPs is mainly to recognise the genomic locations that can be used to categorise the virus strain in India. Not withstanding these, once the strain of the virus is identified, the proper vaccine can be used. In future, these SNPs can be used for protein modelling so that drugs can be designed to target such proteins.
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